Ruth Oren Hommonai
Chief Executive Officer at INTER GAMMA INVESTMENT COMPANY LTD
Ruth Oren Hommonai active positions
| Companies | Position | Start | End |
|---|---|---|---|
| INTER GAMMA INVESTMENT COMPANY LTD | Chief Executive Officer | 31/12/2013 | - |
| Director/Board Member | 26/08/2009 | - | |
| General Counsel | - | - | |
| Corporate Secretary | - | - |
Career history of Ruth Oren Hommonai
Former positions of Ruth Oren Hommonai
| Companies | Position | Start | End |
|---|---|---|---|
Dexcel Pharma Technologies Ltd.
 Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel. | General Counsel | - | - |
Training of Ruth Oren Hommonai
| Tel-Aviv University | Graduate Degree |
| The Interdisciplinary Center Herzliya | Masters Business Admin |
Statistics
International
| Israel | 5 |
Operational
| General Counsel | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Consumer Services | 3 |
| Finance | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| INTER GAMMA INVESTMENT COMPANY LTD | Finance |
| Private companies | 1 |
|---|---|
Dexcel Pharma Technologies Ltd.
Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel. | Health Technology |
- Stock Market
- Insiders
- Ruth Oren Hommonai
- Experience
